Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 10227
Country/Region: Zambia
Year: 2015
Main Partner: Provincial Health Office - Western Province
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $5,163,154 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $900,000
Care: TB/HIV (HVTB) $700,000
Care: Pediatric Care and Support (PDCS) $300,000
Laboratory Infrastructure (HLAB) $100,000
Strategic Information (HVSI) $160,000
Health Systems Strengthening (OHSS) $203,606
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $215,936
Testing: HIV Testing and Counseling (HVCT) $509,308
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $380,000
Treatment: Adult Treatment (HTXS) $1,360,000
Treatment: Pediatric Treatment (PDTX) $334,304
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 2
CARE_CURR Age/sex: <1 Female 2016 2
CARE_CURR Age/sex: <1 Male 2016 1
CARE_CURR Age/sex: 1-4 Female 2016 871
CARE_CURR Age/sex: 1-4 Female 2016 143
CARE_CURR Age/sex: 1-4 Male 2016 845
CARE_CURR Age/sex: 1-4 Male 2016 139
CARE_CURR Age/sex: 10-14 Female 2016 1,909
CARE_CURR Age/sex: 10-14 Female 2016 316
CARE_CURR Age/sex: 10-14 Male 2016 1,321
CARE_CURR Age/sex: 10-14 Male 2016 216
CARE_CURR Age/sex: 15-19 Female 2016 1,894
CARE_CURR Age/sex: 15-19 Female 2016 312
CARE_CURR Age/sex: 15-19 Male 2016 1,363
CARE_CURR Age/sex: 15-19 Male 2016 222
CARE_CURR Age/sex: 20-24 Female 2016 2,679
CARE_CURR Age/sex: 20-24 Female 2016 442
CARE_CURR Age/sex: 20-24 Male 2016 1,955
CARE_CURR Age/sex: 20-24 Male 2016 318
CARE_CURR Age/sex: 25-49 Female 2016 3,306
CARE_CURR Age/sex: 25-49 Female 2016 558
CARE_CURR Age/sex: 25-49 Male 2016 2,303
CARE_CURR Age/sex: 25-49 Male 2016 374
CARE_CURR Age/sex: 5-9 Female 2016 1,869
CARE_CURR Age/sex: 5-9 Female 2016 310
CARE_CURR Age/sex: 5-9 Male 2016 1,262
CARE_CURR Age/sex: 5-9 Male 2016 207
CARE_CURR Age/sex: 50+ Female 2016 477
CARE_CURR Age/sex: 50+ Female 2016 80
CARE_CURR Age/sex: 50+ Male 2016 401
CARE_CURR Age/sex: 50+ Male 2016 66
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 4,647
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 771
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 3,404
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 563
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 8,448
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 1,392
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 5,958
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 980
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 22,457
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,706
CARE_CURR Sum of Age/Sex disaggregates 2016 22,457
CARE_CURR Sum of Age/Sex disaggregates 2016 3,706
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 22,457
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 3,706
CARE_NEW Age/sex: <1 Female 2016 2
CARE_NEW Age/sex: <1 Male 2016 1
CARE_NEW Age/sex: 1-4 Female 2016 193
CARE_NEW Age/sex: 1-4 Male 2016 188
CARE_NEW Age/sex: 10-14 Female 2016 426
CARE_NEW Age/sex: 10-14 Male 2016 291
CARE_NEW Age/sex: 15-19 Female 2016 421
CARE_NEW Age/sex: 15-19 Male 2016 300
CARE_NEW Age/sex: 20-24 Female 2016 598
CARE_NEW Age/sex: 20-24 Male 2016 429
CARE_NEW Age/sex: 25-49 Female 2016 704
CARE_NEW Age/sex: 25-49 Male 2016 504
CARE_NEW Age/sex: 5-9 Female 2016 418
CARE_NEW Age/sex: 5-9 Male 2016 280
CARE_NEW Age/sex: 50+ Female 2016 108
CARE_NEW Age/sex: 50+ Male 2016 88
CARE_NEW Aggregated Age/sex: <15 Female 2016 1,035
CARE_NEW Aggregated Age/sex: <15 Male 2016 757
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,842
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,317
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 4,951
CARE_NEW Sum of Age/sex disaggregates 2016 4,951
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 4,951
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 4,951
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 12
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 12
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 7,683
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 766
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 5,617
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 559
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 14,259
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 1,388
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 10,289
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,017
HTS_TST By Test Result: Negative 2016 34,857
HTS_TST By Test Result: Negative 2016 3,435
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 37,848
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 3,730
HTS_TST Sum of Aggregated Age/Sex <15 2016 13,300
HTS_TST Sum of Aggregated Age/Sex <15 2016 1,325
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 24,548
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 2,405
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 37,848
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 3,730
HTS_TST Sum of Test Result disaggregates 2016 37,848
HTS_TST Sum of Test Result disaggregates 2016 3,730
HTS_TST_POS By Test Result: Positive 2016 2,991
HTS_TST_POS By Test Result: Positive 2016 295
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 1
LAB_CAP By clinical laboratories 2016 1
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 1
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 582
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 305
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 582
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 305
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 582
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 305
PMTCT_ARV Sum of New and Current disaggregates 2016 582
PMTCT_ARV Sum of New and Current disaggregates 2016 305
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 100
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 98
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 198
PMTCT_EID Sum of Infant Age disaggregates 2016 198
PMTCT_STAT By: Known positives at entry 2016 41
PMTCT_STAT By: Number of new positives identified 2016 582
PMTCT_STAT By: Number of new positives identified 2016 264
PMTCT_STAT Number of new ANC and L&D clients 2016 15,836
PMTCT_STAT Number of new ANC and L&D clients 2016 3,687
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 15,836
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 3,687
PMTCT_STAT Sum of Positives Status disaggregates 2016 582
PMTCT_STAT Sum of Positives Status disaggregates 2016 305
PP_PREV Age/sex: 10-14 Female 2016 662
PP_PREV Age/sex: 10-14 Male 2016 609
PP_PREV Age/sex: 15-19 Female 2016 1,773
PP_PREV Age/sex: 15-19 Male 2016 1,626
PP_PREV Age/sex: 20-24 Female 2016 3,628
PP_PREV Age/sex: 20-24 Male 2016 3,274
PP_PREV Age/sex: 25-49 Female 2016 5,011
PP_PREV Age/sex: 25-49 Male 2016 4,590
PP_PREV Age/sex: 50+ Female 2016 1,414
PP_PREV Age/sex: 50+ Male 2016 1,221
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 23,808
PP_PREV Sum of Age/Sex disaggregates 2016 23,808
PP_PREV Total number of people in the target population 2016 198,860
TB_ART Aggregated Age: 15+ 2016 31
TB_ART Female 2016 21
TB_ART Male 2016 10
TB_ART Sum of Aggregated Age disaggregates 2016 31
TB_ART Sum of Sex disaggregates 2016 31
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 31
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 31
TB_SCREEN Age: 10-14 2016 10
TB_SCREEN Age: 15-19 2016 14
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 10
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 856
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 22,457
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,706
TB_SCREEN Sex: Female 2016 423
TB_SCREEN Sex: Male 2016 442
TB_SCREEN Sum of Age disaggregates 2016 866
TB_SCREEN Sum of Aggregated Age disaggregates 2016 866
TB_SCREEN Sum of Sex disaggregates 2016 865
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 866
TX_CURR Age/Sex: <1 Female 2016 43
TX_CURR Age/Sex: <1 Female 2016 47
TX_CURR Age/Sex: <1 Male 2016 36
TX_CURR Age/Sex: <1 Male 2016 34
TX_CURR Age/Sex: 1-4 Female 2016 272
TX_CURR Age/Sex: 1-4 Female 2016 528
TX_CURR Age/Sex: 1-4 Male 2016 198
TX_CURR Age/Sex: 1-4 Male 2016 482
TX_CURR Age/Sex: 5-14 Female 2016 1,019
TX_CURR Age/Sex: 5-14 Female 2016 697
TX_CURR Age/Sex: 5-14 Male 2016 856
TX_CURR Age/Sex: 5-14 Male 2016 783
TX_CURR Aggregated Age/Sex: <1 Female 2016 43
TX_CURR Aggregated Age/Sex: <1 Female 2016 47
TX_CURR Aggregated Age/Sex: <1 Male 2016 36
TX_CURR Aggregated Age/Sex: <1 Male 2016 34
TX_CURR Aggregated Age/Sex: 15+ Female 2016 9,221
TX_CURR Aggregated Age/Sex: 15+ Female 2016 9,749
TX_CURR Aggregated Age/Sex: 15+ Male 2016 7,250
TX_CURR Aggregated Age/Sex: 15+ Male 2016 7,198
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 18,895
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 19,441
TX_CURR Sum of age/sex disaggregates 2016 19,441
TX_CURR Sum of Age/Sex disaggregations 2016 18,895
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 2,424
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 2,494
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 16,471
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 16,947
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 16,471
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 16,947
TX_NEW Aggregated Grouping by Age: <1 Male 2016 2
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 2
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 1,833
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 1,442
TX_NEW Breastfeeding status 2016 11
TX_NEW By Age/Sex: <1 Female 2016 2
TX_NEW By Age/Sex: <1 Male 2016 2
TX_NEW By Age/Sex: 1-4 Female 2016 233
TX_NEW By Age/Sex: 1-4 Male 2016 44
TX_NEW By Age/Sex: 10-14 Female 2016 134
TX_NEW By Age/Sex: 10-14 Male 2016 115
TX_NEW By Age/Sex: 15-19 Female 2016 411
TX_NEW By Age/Sex: 15-19 Male 2016 270
TX_NEW By Age/Sex: 20-24 Female 2016 426
TX_NEW By Age/Sex: 20-24 Male 2016 504
TX_NEW By Age/Sex: 25-49 Female 2016 887
TX_NEW By Age/Sex: 25-49 Male 2016 586
TX_NEW By Age/Sex: 5-9 Female 2016 259
TX_NEW By Age/Sex: 5-9 Male 2016 68
TX_NEW By Age/Sex: 50+ Female 2016 106
TX_NEW By Age/Sex: 50+ Male 2016 84
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 4,131
TX_NEW Pregnancy status 2016 48
TX_NEW Sum of Age/Sex disaggregates 2016 4,131
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 3,275
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 3,214
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 3,299
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 47
VMMC_CIRC By Age: <1 2016 39
VMMC_CIRC By Age: 10-14 2016 596
VMMC_CIRC By Age: 15-19 2016 1,033
VMMC_CIRC By Age: 20-24 2016 1,252
VMMC_CIRC By Age: 50+ 2016 50
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 4,664
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2016 70
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 4,594
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 869
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 3,795
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 4,664
VMMC_CIRC Sum of age disaggregates 2016 2,970